A Study Assessing KB407 for the Treatment of Cystic Fibrosis
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Recruiting · NCT05504837 · Registry updated 2026-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Assessing KB407 for the Treatment of Cystic Fibrosis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Phase 1 | 2026-05-07 | NCT05504837 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Krystal Biotech, Inc. | 11 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Health Wake Forest Baptist Medical Center | Winston-Salem | United States | 15 |
| New York Medical College/ Boston Children's Health Physicians | Hawthorne | United States | 1 |
| Northwell Health Physicians | New York | United States | 1 |
| St. Lukes CF Center of Idaho | Boise | United States | 1 |
| The Cystic Fibrosis Institute | Northfield | United States | 2 |
| University of Florida, Gainesville | Gainesville | United States | 4 |